Last reviewed · How we verify

NCT03062787: EEFFEK

Early Effect of Cingal® Compared to Monovisc® in Patients With Osteoarthritis of the Knee

Completed NA Last updated 21 April 2020
What this trial tests

NA trial testing Cingal® (Hyaluronic Acid plus Triamcinolone Hexacetonide) in Osteoarthritis, Knee in 60 participants. Completed in 25 October 2017.

Timeline
5 April 2017
Primary endpoint
25 October 2017
25 October 2017

Quick facts

Lead sponsorPharmascience Inc.
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment60
Start date5 April 2017
Primary completion25 October 2017
Estimated completion25 October 2017
Sites5 locations across Canada

Drugs / interventions tested

Conditions studied

Sponsor

Pharmascience Inc. — full company profile →

Who can join

18 and older, any sex, with Osteoarthritis, Knee. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

It is a post-license, multicenter, randomized, single blind, controlled study comparing a single injection of Cingal® (study arm) with a single injection of Monovisc® (control arm).

Publications & conference data

3 peer-reviewed publications reference this trial (live from Europe PMC):

  1. Designing functional hyaluronic acid-based hydrogels for cartilage tissue engineering.
    Wang M, Deng Z, Guo Y, Xu P. · · 2022 · cited 52× · PMID 36420054 · DOI 10.1016/j.mtbio.2022.100495
  2. Recent Advances in Clinical Translation of Intra-Articular Osteoarthritis Drug Delivery Systems.
    DeJulius CR, Gulati S, Hasty KA, Crofford LJ, et al · · 2021 · cited 30× · PMID 33709019 · DOI 10.1002/adtp.202000088
  3. Pharmaceutical therapeutics for articular regeneration and restoration: state-of-the-art technology for screening small molecular drugs.
    Chen Y, Sun H, Yao X, Yu Y, et al · · 2021 · cited 9× · PMID 34783870 · DOI 10.1007/s00018-021-03983-8

Verify or expand the search:

Other recruiting trials for Osteoarthritis, Knee

Currently open trials in the same condition.

Other Pharmascience Inc. trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03062787.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing